Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 4561

1.

Venous thromboembolism (VTE) prophylaxis and urological pelvic cancer surgery: a UK national audit.

Pridgeon S, Allchorne P, Turner B, Peters J, Green J.

BJU Int. 2015 Feb;115(2):223-9.

PMID:
25756135
2.

Late venous thromboembolism prophylaxis after craniotomy in acute traumatic brain injury.

Daley MJ, Ali S, Brown CV.

Am Surg. 2015 Feb;81(2):207-11.

PMID:
25642886
3.

Development of a hypercoagulable status in patients undergoing off-pump lung transplantation despite prolonged conventional coagulation tests.

Ruitenbeek K, Hugenholtz GC, Adelmeijer J, Pereboom IT, Meijers JC, van der Bij W, Porte RJ, Erasmus ME, Lisman T.

Am J Respir Crit Care Med. 2015 Jan 15;191(2):230-3. doi: 10.1164/rccm.201407-1228LE. No abstract available.

PMID:
25590158
4.

Post-transplant venous thromboembolic events and their effect on graft survival.

Abualhassan N, Aljiffry M, Thalib L, Coussa R, Metrakos P, Hassanain M.

Saudi J Kidney Dis Transpl. 2015 Jan;26(1):1-5.

5.

[Advantages and disadvantages of warfarin and pradaxa therapy for venous thromboembolism].

Sukovatykh BS, Belikov LN, Savchuk OF, Sukovatykh MB.

Vestn Khir Im I I Grek. 2014;173(4):87-91. Russian.

PMID:
25552114
6.

The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.

Sengupta N, Feuerstein JD, Patwardhan VR, Tapper EB, Ketwaroo GA, Thaker AM, Leffler DA.

Am J Gastroenterol. 2015 Feb;110(2):328-35. doi: 10.1038/ajg.2014.398. Epub 2014 Dec 16.

PMID:
25512338
7.

Treatment patterns and outcomes among hospitalized patients with venous thromboembolism in the United States: an analysis of electronic health records data.

Menzin J, Preblick R, Friedman M, Menzin J, Frean M, Jacqueline Kwong W.

Hosp Pract (1995). 2014 Oct;42(4):59-74. doi: 10.3810/hp.2014.10.1143.

PMID:
25502130
8.

Parenteral anticoagulation in ambulatory patients with cancer.

Akl EA, Kahale LA, Ballout RA, Barba M, Yosuico VE, van Doormaal FF, Middeldorp S, Bryant A, Schünemann H.

Cochrane Database Syst Rev. 2014 Dec 10;12:CD006652. doi: 10.1002/14651858.CD006652.pub4. Review.

PMID:
25491949
9.

Venous thromboembolism in cancer patients.

Deng A, Galanis T, Graham MG.

Hosp Pract (1995). 2014 Dec;42(5):24-33. doi: 10.3810/hp.2014.12.1156. Review.

PMID:
25485915
10.

Factor XI antisense oligonucleotide for prevention of venous thrombosis.

Büller HR, Bethune C, Bhanot S, Gailani D, Monia BP, Raskob GE, Segers A, Verhamme P, Weitz JI; FXI-ASO TKA Investigators.

N Engl J Med. 2015 Jan 15;372(3):232-40. doi: 10.1056/NEJMoa1405760. Epub 2014 Dec 7.

PMID:
25482425
11.

Is extended pharmacologic venous thromboembolism prophylaxis uniformly safe after radical cystectomy?

Mehrazin R, Piotrowski Z, Egleston B, Parker D, Tomaszweski JJ, Smaldone MC, Abbosh PH, Ito T, Bloch P, Iffrig K, Bilusic M, Chen DY, Viterbo R, Greenberg RE, Uzzo RG, Kutikov A.

Urology. 2014 Nov;84(5):1152-6. doi: 10.1016/j.urology.2014.06.058. Epub 2014 Oct 24.

PMID:
25443917
12.

Preoperative dosing of low-molecular-weight heparin in hepatopancreatobiliary surgery.

Doughtie CA, Priddy EE, Philips P, Martin RC, McMasters KM, Scoggins CR.

Am J Surg. 2014 Dec;208(6):1009-15; discussion 1015. doi: 10.1016/j.amjsurg.2014.08.012. Epub 2014 Sep 28.

PMID:
25435300
13.

Diagnosis, treatment, and prevention of venous thromboembolism in pregnancy.

Marshall AL.

Postgrad Med. 2014 Nov;126(7):25-34. doi: 10.3810/pgm.2014.11.2830. Review.

PMID:
25387211
14.

Lower limb joint replacement in patients with a history of venous thromboembolism.

Allen D, Sale G.

Bone Joint J. 2014 Nov;96-B(11):1515-9. doi: 10.1302/0301-620X.96B11.33492.

PMID:
25371466
15.

[What kind of thrombosis prevention for travel?].

Stiefelhagen P.

MMW Fortschr Med. 2014 Jun 26;156(12):20. German. No abstract available.

PMID:
25369671
17.

Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.

Fowler RA, Mittmann N, Geerts W, Heels-Ansdell D, Gould MK, Guyatt G, Krahn M, Finfer S, Pinto R, Chan B, Ormanidhi O, Arabi Y, Qushmaq I, Rocha MG, Dodek P, McIntyre L, Hall R, Ferguson ND, Mehta S, Marshall JC, Doig CJ, Muscedere J, Jacka MJ, Klinger JR, Vlahakis N, Orford N, Seppelt I, Skrobik YK, Sud S, Cade JF, Cooper J, Cook D; Canadian Critical Care Trials Group; Australia and New Zealand Intensive Care Society Clinical Trials Group.

JAMA. 2014 Nov 26;312(20):2135-45. doi: 10.1001/jama.2014.15101.

PMID:
25362228
18.

Antithrombotic drugs.

[No authors listed]

Med Lett Drugs Ther. 2014 Oct 27;56(1454):103-9; quiz 1 p following 109. Review. No abstract available.

PMID:
25337986
19.

Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.).

Kreher S, Ochsenreither S, Trappe RU, Pabinger I, Bergmann F, Petrides PE, Koschmieder S, Matzdorff A, Tiede A, Griesshammer M, Riess H; Haemostasis Working Party of the German Society of Hematology and Oncology; Austrian Society of Hematology and Oncology; Society of Thrombosis and Haemostasis Research.

Ann Hematol. 2014 Dec;93(12):1953-63. doi: 10.1007/s00277-014-2224-8. Epub 2014 Oct 14.

PMID:
25307456
20.

Chemoprophylaxis for venous thromboembolism in otolaryngology.

Bahl V, Shuman AG, Hu HM, Jackson CR, Pannucci CJ, Alaniz C, Chepeha DB, Bradford CR.

JAMA Otolaryngol Head Neck Surg. 2014 Nov;140(11):999-1005. doi: 10.1001/jamaoto.2014.2254.

PMID:
25275427
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk